Assessment of the risk of sarcopenia in individuals with type 2 diabetes
DOI:
https://doi.org/10.12957/demetra.2024.73598Abstract
Introduction: Individuals with diabetes often experience an accentuated loss of muscle mass and strength. Thus, the SARC-F and SARC-CALF screening tools are useful for the investigation of the risk of sarcopenia. Objective: Associate the risk of sarcopenia with sociodemographic, economic, clinical, anthropometric and lifestyle variables in individuals with diabetes. Methods: A case-series study was conducted involving male and female adults with type 2 diabetes between 20 and 59 years of age. The assessment of the risk of diabetes was performed using the SARC-F and SARC-CALF instruments. Data were collected on sociodemographic-economic variables, anthropometric measures, clinical conditions and lifestyle for the characterization of the sample and to test associations with the risk of sarcopenia. Results: The sample was composed of 69 patients, with a mean age of 53 ± 7.5 years and a predominance of women (63.8%; 95%CI: 50.7-75.4). The prevalence of risk of sarcopenia was 43.48% and 46.38% based on the SARC-F and SARC-CALF, respectively. Using the SARC-F, no significant associations were found with the variables of interest. Using the SARC-CALF, however, the risk of sarcopenia was associated with body mass index (p < 0.001), waist circumference (p < 0.001) and smoking habit (p = 0.027). Conclusion: Approximately half of the individuals analyzed were at risk of sarcopenia. The SARC-CALF questionnaire was associated with anthropometric variables and the smoking habit and can be considered adequate for the assessment of the risk of sarcopenia, enabling early, effective interventions.
Downloads
References
REFERÊNCIAS
Cruz-Jentoft AJ, Baeyenns JP, Bauer JM, Boirie Y, Cederholm T, Francesco Landi F. et al. Writing Group for the European Working Group on Sarcopenia in Older People 2 (EWGSOP2), and the Extended Group for EWGSOP2. Sarcopenia: revised European consensus on definition and diagnosis. Age and ageing. 2019;48(1):16-31. https://doi.org/10.1093/ageing/afy169.
Pontes VDCB.Sarcopenia: rastreio, diagnóstico e manejo clínico. Journal of Hospital Sciences. 2º de setembro de 2022;2(1):4-14. [Acesso 18 nov 2022]. Disponível em: https://jhsc.emnuvens.com.br/revista/article/view/32
Cruz-Jentoft AJ, Baeyens JP, Bauer JM Boirie Y, Cederholm T, Francesco Landi F et al. Sarcopenia: European consensus on definition and diagnosis: report of the European working group on sarcopenia in older people. Age Ageing 2010;39:412–23.
Sarodnik C, Bours, SPG, Schaper NC, Van Den Bergh JP, Van Geel, TACM. The risks of sarcopenia, falls and fractures in patients with type 2 diabetes mellitus. Maturitas. 2018;109:70-77. https://doi.org/10.1016/j.maturitas.2017.12.011
Malmstrom TK, Miller DK, Simonsick EM, Ferrucci L, Morley JE. SARC-F: a symptom score to predict persons with sarcopenia at risk for poor functional outcomes. J Cachexia Sarcopenia Muscle. 2016;7(1):28-36.
https://doi.org/10.1002/jcsm.12048
Krzymińska-Siemaszko R, Deskur-Śmielecka E, Kaluźniak-Szymanowska A, Lewandowicz M, Wieczorowska-Tobis K. Comparison of Diagnostic Performance of SARC-F and Its Two Modified Versions (SARC-CalF and SARC-F+EBM) in Community-Dwelling Older Adults from Poland. Clinical Interventions Aging. 2020;15:583-594. https://doi.org/10.2147/CIA.S250508
Barbosa-Silva TG, Menezes AMB, Bielemann RM, Malmstrom TK, Gonzalez MC. Enhancing SARC-F: Improving Sarcopenia Screening in the Clinical Practice. J Am Med Dir Assoc. 2016;17(12):1136-41. https://doi.org/10.1016/j.jamda.2016.08.004
Cristaldo MRA, Guandalini VR, Faria SDO, Spexoto MCB. Screening the risk of sarcopenia in adults aged 50 years or older hospitalized. Revista Brasileira de Geriatria e Gerontologia. 2021;24(2):e210016.
https://doi.org/10.1590/1981-22562021024.210016pub-date
Sociedade Brasileira de Diabetes. Diretrizes da Sociedade Brasileira de Diabetes 2019-2020: gestão biênio 2018-2019. Clannad Editora Científica, 2019. [Acesso 18 Nov 2022]. Disponível em: https://edisciplinas.usp.br/pluginfile.php/5730478/mod_resource/content/0/Diretrizes-SBD-2019-2020.pdf
Lohman TG, Roche AF, Martorell R. Anthropometric standardization reference manual. [Sem local]: Human Kinetics Books; 1988.
World Health Organization. Physical Status: the use and interpretation of anthropometry. Geneva: World Health Organization; 1995. (WHO Technical Report Series, n. 854)
World Health Organization. Obesity: preventing and managing the global epidemic. Geneva: World Health Organization; 2000, 894;1-253.
Matsudo S, Araújo T, Matsudo V, Andrade D, Andrade E, Oliveira C, et al. Questionário Internacional de Atividade Física (IPAQ): estudo de validade e reprodutibilidade no Brasil. Rev Bras Ativ Fís Saúde. 2001;6(2):5-12 [citado 18 nov 2022];
Dsponível em: file:///C:/Users/windows%2010/Downloads/josecazuzajunior,+Gerente+da+revista,+213.pdf
Silva MAD, Sousa AGMR, Schargodsky, H. Risk factors for acute myocardial infarction in Brazil (FRICAS study). Arquivos brasileiros de cardiologia, 1998;71(5),667-675.
https://doi.org/10.1590/S0066-782X1998001100005
Xu Z, Zhang P, Chen Y, Jiang J, Zhou Z, Zhu H. Comparing SARC-CalF With SARC-F for Screening Sarcopenia in Adults With Type 2 Diabetes Mellitus. Frontiers in Nutrition. 2022;9:803924. https://doi.org/10.3389/fnut.2022.803924
Peixoto LG, Barbosa CD, Nahas PC, Rossato, LT, Oliveira EP. A circunferência da panturrilha está associada com a massa muscular de indivíduos hospitalizados. Rev Bras Nutr Clin 2016;31(2):167-71
Geraci A, Calvani R, Ferri E, Marzetti E, Arosio B,Cesari M. Sarcopenia and menopause: the role of estradiol. Frontiers in Endocrinology. 2021;12:682012. https://doi.org/10.3389/fendo.2021.682012
Kim MJ, YabushitaN,Tanaka K. Exploring effective items of physical function in slow walking speed and self‐reported mobility limitation in community‐dwelling older adults. Geriatrics & gerontology international, 2012;12(1), 50-58.
https://doi.org/10.1111/j.1447-0594.2011.00726.x
Wilson D, Jackson T, SapeyE,Lord JM. Frailty and sarcopenia: the potential role of an aged immune system. Ageing research reviews, 2017;36:1-10. https://doi.org/10.1016/j.arr.2017.01.006
Machado A, Vieira MCU. Impacto de fatores socioeconômicos na funcionalidade da pessoa idosa portadora de condições crônicas.Rev Enfermagem UFSM. 2015;5(1):81-91. https://doi.org/10.5902/2179769213703
Torres MRS, Oliveira LB, Peixoto MI. Associação entre sarcopenia e história de fraturas em pacientes com diabetes tipo 2. Medicina (Ribeirão Preto). 2020;53(4):389-397.
https://doi.org/10.11606/issn.2176-7262.v53i4p389-397
Umegaki H. Sarcopenia and frailty in older patients with diabetes mellitus. Geriatrics & gerontology international. 2016;16(3):293-299. https://doi.org/10.1111/ggi.12688.
Dionyssiotis Y,Kapsokoulou A, Samlidi E, Angoules AG, Papathanasiou J, Chronopoulos E, et al. Sarcopenia: from definition to treatment. Hormones. 2017;16:429–439. https://doi.org/10.14310/horm.2002.1764
Dionyssiotis Y, Athanassiou P, Papathanasiou J, Efstathopoulos E, Prokopidis K, Trovas G, Kostoglou-Athanassiou I et al. Sarcopenia in patients with diabetes mellitus. Folia medica. 2022;64(4):596-601. https://doi.org/ 10.3897/folmed.64.e63530
Rossi AP; Rubele S, Zamboni M. Sarcopenic Obesity. In: Nutrition and Skeletal Muscle. Academic Press. 2019;83-92.
https://doi.org/10.1016/B978-0-12-810422-4.00006-3
Oliveira NC, Miraglia F, Tadini FSM, Filippin LI. Sarcopenia e estado nutricional de idosos residentes em uma comunidade no sul do brasil. Estud interdisciplinar envelhec . 2021;25(2).
https://doi.org/10.22456/2316-2171.93453
Dutra MT, Leite MM, Gadelha AB. Atividade física, diabetes mellitus e obesidade sarcopênica em uma comunidade urbana do distrito federal. In: Educação Física e Ciências do Esporte: Uma Abordagem Interdisciplinar – Volume 2. 1ª edição. Editora Científica Digital; 2020:8293.
https://doi.org/ 10.37885/201202389
Zamboni M , Macchi F, Nori N, Rossi AP. Sarcopenic obesity. Sarcopenia, 2021:147-156. https://doi.org/ 10.1002/9781119597896.ch12
Ahn H, Kim DW, Ko Y, Ha J, Shin YB, Lee J, et al. Updated systematic review and meta-analysis on diagnostic issues and the prognostic impact of myosteatosis: A new paradigm beyond sarcopenia. Ageing Res Rev. 2021;70:101398. https://doi.org/10.1016/j.arr.2021.10139
Aleixo GFP, Yu H, Chen YT, Nyrop KA, Louie RJ, Deal AM, et al. Myosteatosis evaluation using erector spinae and psoas muscles to predict adverse events during adjuvant chemotherapy for breast cancer. Breast Cancer Res Treat. 2021;186(2):487-495.
https://doi.org/10.1007/s10549-020-06061-y
Santos VR, Araujo MYC, Cardoso MR, Batista VC, Christofaro DGD,Gobbo LA. Association of insufficient physical activity with sarcopenia and sarcopenic obesity in individuals aged 50 years or more. Revista de Nutrição.2017;30(2):175-184.
https://doi.org/10.1590/1678-98652017000200003
Barbosa‐Silva TG, Bielemann RM, Gonzalez MC, Menezes AMB. Prevalence of sarcopenia among community‐dwelling elderly of a medium‐sized South American city: results of the COMO VAI? study. Journal of Cachexia, Sarcopenia and Muscle. 2016;7(2):136-143. https://doi.org/10.1002/jcsm.12049
Rom O, Kaisari S, Aizenbud D, Reznick AZ. Lifestyle and sarcopenia-etiology, prevention, and treatment. Rambam Maimonides Med. J. 2012;3(4):E0024. https://doi.org/10.5041/RMMJ.10091.
Confortini SC, Ono LM, Barbosa AR, D’Orsi E. Sarcopenia e sua associação com mudanças nos fatores socioeconômicos, comportamentais e de saúde: Estudo EpiFloripa Idoso. Cad Saúde Pública. 2018;34(12).
https://doi.org/10.1590/0102-311x00164917
Castillo EM, Goodman-Gruen D, Kritz-Silverstein D, Morton DJ, Wingard DL, Barrett-Connor E. Sarcopenia in elderly men and women: the Rancho Bernardo study. American journal of preventive medicine. 2003;25(3):226-231. https://doi.org/10.1016/S0749-3797(03)00197-1
Szulc P, Duboeuf F, Marchand F, Delmas PD. Hormonal and lifestyle determinants of appendicular skeletal muscle mass in men: the MINOS study. The American journal of clinical nutrition. 2004;80(2):496-503.
https://doi.org/10.1093/ajcn/80.2.496
Kok MO, Hoekstra T, Twisk JW. The longitudinal relation between smoking and muscle strength in healthy adults. European addiction research. 2012;18(2):70-75. https://doi.org/10.1159/000333600
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Juliane Ramos Costa Lima
This work is licensed under a Creative Commons Attribution 4.0 International License.
STATEMENT OF AUTHORSHIP RESPONSIBILITY
Title of the manuscript:
________________________________________________________
1. Statement of responsability
I certify that I have participated in the work above specified and take public responsibility for its content.
I certify that the manuscript represents an original work and that none of the material in the manuscript has been previously published, is included in another manuscript, or is currently under consideration for publication elsewhere, whether in printed form or in electronic media, except that described in the attachment.
In case of acceptance of this text by Demetra: Alimentação, Nutrição & Saude, I declare to be in accordance with the policy of public access and copyright adopted by Demetra, which provides as follows: (a) the authors retain the copyright and grant to the Journal the right of first publication, the work being simultaneously licensed under the Creative Commons Attribution License, which allows the sharing of the work with acknowledgment of authorship and initial publication in this journal; (b) authors are authorized to enter additional contracts separately for non-exclusive distribution of the version of the work published in this journal (eg, publishing in institutional repository or book chapter), with acknowledgment of authorship and initial publication in this journal; and (c) authors are permitted and encouraged to post and distribute their work online (eg, in institutional repositories or on their personal page) at any point before or during the editorial process, as this may lead to productive changes, as well as increase the impact and citation of the published work.
2. Conflict of Interest Statement
I certify that there is no conflict of interest in connection with the submitted article.
Date, signature and full address of all authors.
